Short talks Pharmacology 5
Drug transport, metabolism and pharmacogenomics

Programme

• 09:00 – 09:15 10 Min. 5 Min.

  • Oral presentation
  • 21

  P-glycoprotein inhibition by rifabutin distinguishes it from rifampicin and partly explains the unequal drug interaction risk

  • Julie Nilles (Heidelberg / DE)

   Drug transport/delivery and metabolism, Pharmacokinetics and PK/PD modelling
• 09:15 – 09:30 10 Min. 5 Min.

  • Oral presentation
  • 23

  Influence of single nucleotide polymorphism c.825C>T in GNB3 on humoral and cellular immune response after vaccination with mRNA-1273 vaccine

  • Ieva Ciuciulkaite (Essen / DE)

   Immunopharmacology / inflammation / anti-infectives , Pharmacogenomics and personalized medicine
• 09:30 – 09:45 10 Min. 5 Min.

  • Oral presentation
  • 22

  Metabolomic profiling and in silico ligand screening enable identification of novel drug transporter substrates

  • Anne T. Nies (Stuttgart / DE)

   Drug transport/delivery and metabolism, Ion channels and membrane transporters
• 09:45 – 10:00 10 Min. 5 Min.

  • Oral presentation
  • 24

  Pharmacogenetics in uncoupling susceptibility of CYP2B6 mediated substrate oxidation

  • Sabrina Yamoune (Aachen / DE)

   Cancer pharmacology , Pharmacogenomics and personalized medicine
• 10:00 – 10:15 10 Min. 5 Min.

  • Oral presentation
  • 25

  Voriconazole clearance can be predicted by CYP3A and CYP2C19 activity using microdosed probe drugs

  • Amin Muhareb (Heidelberg / DE)

   Pharmacokinetics and PK/PD modelling